BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 9350868)

  • 1. Intracellular targeting of exoenzyme S of Pseudomonas aeruginosa via type III-dependent translocation induces phagocytosis resistance, cytotoxicity and disruption of actin microfilaments.
    Frithz-Lindsten E; Du Y; Rosqvist R; Forsberg A
    Mol Microbiol; 1997 Sep; 25(6):1125-39. PubMed ID: 9350868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exoenzyme T of Pseudomonas aeruginosa elicits cytotoxicity without interfering with Ras signal transduction.
    Sundin C; Henriksson ML; Hallberg B; Forsberg A; Frithz-Lindsten E
    Cell Microbiol; 2001 Apr; 3(4):237-46. PubMed ID: 11298647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular expression of the ADP-ribosyltransferase domain of Pseudomonas exoenzyme S is cytotoxic to eukaryotic cells.
    Pederson KJ; Barbieri JT
    Mol Microbiol; 1998 Nov; 30(4):751-9. PubMed ID: 10094623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of Yersinia Yop-effector delivery by translocated YopE.
    Aili M; Isaksson EL; Carlsson SE; Wolf-Watz H; Rosqvist R; Francis MS
    Int J Med Microbiol; 2008 Apr; 298(3-4):183-92. PubMed ID: 17597003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The RhoGAP activity of the Yersinia pseudotuberculosis cytotoxin YopE is required for antiphagocytic function and virulence.
    Black DS; Bliska JB
    Mol Microbiol; 2000 Aug; 37(3):515-27. PubMed ID: 10931345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The amino-terminal domain of Pseudomonas aeruginosa ExoS disrupts actin filaments via small-molecular-weight GTP-binding proteins.
    Pederson KJ; Vallis AJ; Aktories K; Frank DW; Barbieri JT
    Mol Microbiol; 1999 Apr; 32(2):393-401. PubMed ID: 10231494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ecto-ADP-ribosyltransferase activity of Pseudomonas aeruginosa exoenzyme S.
    Knight DA; Barbieri JT
    Infect Immun; 1997 Aug; 65(8):3304-9. PubMed ID: 9234791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of Ras in eukaryotic cells by Pseudomonas aeruginosa exoenzyme S.
    McGuffie EM; Frank DW; Vincent TS; Olson JC
    Infect Immun; 1998 Jun; 66(6):2607-13. PubMed ID: 9596723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ADP-ribosylation by exoenzyme T of Pseudomonas aeruginosa induces an irreversible effect on the host cell cytoskeleton in vivo.
    Sundin C; Hallberg B; Forsberg A
    FEMS Microbiol Lett; 2004 May; 234(1):87-91. PubMed ID: 15109724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ras effector pathway activation by epidermal growth factor is inhibited in vivo by exoenzyme S ADP-ribosylation of Ras.
    Henriksson ML; Rosqvist R; Telepnev M; Wolf-Watz H; Hallberg B
    Biochem J; 2000 Apr; 347 Pt 1(Pt 1):217-22. PubMed ID: 10727422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The exoenzyme S regulon of Pseudomonas aeruginosa.
    Frank DW
    Mol Microbiol; 1997 Nov; 26(4):621-9. PubMed ID: 9427393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ADP-ribosyltransferase domain of the effector protein ExoS inhibits phagocytosis of Pseudomonas aeruginosa during pneumonia.
    Rangel SM; Logan LK; Hauser AR
    mBio; 2014 Jun; 5(3):e01080-14. PubMed ID: 24917597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Independent and coordinate effects of ADP-ribosyltransferase and GTPase-activating activities of exoenzyme S on HT-29 epithelial cell function.
    Fraylick JE; La Rocque JR; Vincent TS; Olson JC
    Infect Immun; 2001 Sep; 69(9):5318-28. PubMed ID: 11500401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudomonas aeruginosa ExoS ADP-ribosyltransferase inhibits ERM phosphorylation.
    Maresso AW; Deng Q; Pereckas MS; Wakim BT; Barbieri JT
    Cell Microbiol; 2007 Jan; 9(1):97-105. PubMed ID: 16889625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of recombinant exoenzyme S of Pseudomonas aeruginosa.
    Kulich SM; Frank DW; Barbieri JT
    Infect Immun; 1995 Jan; 63(1):1-8. PubMed ID: 7806344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Auto-ADP-ribosylation of Pseudomonas aeruginosa ExoS.
    Riese MJ; Goehring UM; Ehrmantraut ME; Moss J; Barbieri JT; Aktories K; Schmidt G
    J Biol Chem; 2002 Apr; 277(14):12082-8. PubMed ID: 11821389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic relationship between the 53- and 49-kilodalton forms of exoenzyme S from Pseudomonas aeruginosa.
    Yahr TL; Barbieri JT; Frank DW
    J Bacteriol; 1996 Mar; 178(5):1412-9. PubMed ID: 8631719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-activity relationships for inhibitors of Pseudomonas aeruginosa exoenzyme S ADP-ribosyltransferase activity.
    Saleeb M; Sundin C; Aglar Ö; Pinto AF; Ebrahimi M; Forsberg Å; Schüler H; Elofsson M
    Eur J Med Chem; 2018 Jan; 143():568-576. PubMed ID: 29207339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Examining the role of actin-plasma membrane association in Pseudomonas aeruginosa infection and type III secretion translocation in migratory T24 epithelial cells.
    Bridge DR; Martin KH; Moore ER; Lee WM; Carroll JA; Rocha CL; Olson JC
    Infect Immun; 2012 Sep; 80(9):3049-64. PubMed ID: 22689823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADP-ribosylation of cyclophilin A by Pseudomonas aeruginosa exoenzyme S.
    DiNovo AA; Schey KL; Vachon WS; McGuffie EM; Olson JC; Vincent TS
    Biochemistry; 2006 Apr; 45(14):4664-73. PubMed ID: 16584201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.